By 2003, a Health Affairs analysis found that the United States, with less than 5% of the world's population, accounted for 83.1% of the global ADHD medication market. A 2018 review of U.S. stimulant use echoed the same figure when discussing America's disproportionate share of ADHD medication volume.
Previous Fact Next Fact